Glaucoma observe drops frequently are the at the outset…

glaucoma eye dropsGlaucoma observe drops frequently are the at the outset frugal more than glaucoma surgery and have power to exist surpassingly energetic at controlling IOP to stop bud hurt. Allowing that you are a companionable aspirant according to glaucoma organ of sight drops, you may subsist prescribed in addition than the same form to carry through the superlatively good IOP direct. In deed, numerous company types of glaucoma bud drops be possible to raise the goods of other types.

Depending without ceasing your inaccurate hale condition and other healing stipulations, nevertheless, you may exist a sterile aspirant since glaucoma inspection drops. This is for the reason that medications placed in the observe are absorbed into the conjunctival common ancestry vessels adhering the look on’s exterior. A undisputed percentage of the at work component of the medication, notwithstanding that inconsiderable, resoluteness inscribe the bloodstream and may adversely be drawn toward functions like to the degree that essence duty and aspiration.

Also, more types of look on drops may worsen known but unnamed existing therapeutical terms similar in the manner that asthma. More glaucoma drugs in addition be possible to interact through other for the use of all medications like at the same time that digitalis, prescribed as being essence terms. Such become never-failing you discuss these issues with both your family physician and your eye doctor.

Types of Glaucoma Eye Drops

Glaucoma eye drops are classified by the active ingredient chemical that helps make the drug work. Also, many of the glaucoma eye drops listed here are available in generic forms at your pharmacy.

Prostaglandins. Drugs known as prostaglandins used in eye drops often have the best user compliance because they are required only once daily. Prostaglandins generally work by relaxing muscles in the eye’s interior structure to allow better outflow of fluids, thus reducing buildup of eye pressure.

These drugs have a few common side effects, including stinging and burning when put in the eye, eye color change (darkening of the eye) due to an increase of pigmentation in the iris, and lengthening and curling of the eyelashes. (In fact, the eyelash growth side effect eventually led to the development of an eyelash-lengthening drug called Latisse, which is available by prescription.)

FDA-approved prostaglandins include Xalatan (Pfizer), Lumigan (Allergan), Travatan Z (Alcon) and Rescula (Novartis). Many glaucoma specialists now report that prostaglandins have taken the lead in recent years as a first-line therapy for glaucoma (EyeWorld, January 2007).

Hyperosmotic agents. These drugs are usually for people with a severely high IOP that must be reduced immediately before permanent, irreversible damage occurs to the optic nerve. Hyperosmotic agents reduce IOP by lowering fluid volume in the eye. Usually given only on a one-time, emergency basis, these drugs include oral glycerin and isosorbide orally, and mannitol and urea intravenously.

These eye drops have the potential to reduce heart rate and may cause adverse side effects in individuals with certain heart problems, lung problems (such as emphysema), diabetes, depression or other conditions. For these reasons, make sure you discuss your medical history in detail with your eye doctor before using beta-blockers.

Various glaucoma eye drops are classified by the active ingredient chemical that helps make the drug work.

Examples of beta-blockers used in glaucoma treatment are Timoptic XE (Merck), Istalol (ISTA) and Betoptic S (Alcon).

Alpha-adrenergic agonists. These drugs work by decreasing rate of aqueous humor production and can be used alone or in combination with other anti-glaucoma eye drops.

Common side effects associated with this classification of eye drop include red or bloodshot eyes (ocular injection), upper lid elevation, an enlarged (dilated) pupil and itching. The FDA-approved drugs in this class include Iopidine (Alcon), Alphagan (Allergan). and Alphagan-P (Allergan).

Carbonic anhydrase inhibitors. These drugs work by decreasing rate of aqueous humor production. They are usually used in combination with other anti-glaucoma eye drops and not alone. This classification of drug is also used in oral form (pills). Common side effects experienced with this classification of eye drop include burning, a bitter taste, eyelid reactions and eye redness (ocular injection).

The FDA-approved eye drops in this class include Trusopt (Merck) and Azopt (Alcon). The systemic (pill) form of carbonic anhydrase inhibitors (CAI) are Diamox (Sigma), Neptazane (Wyeth-Ayerst) and Daranide (Merck, Sharp, Dohme). About half of patients cannot tolerate oral CAIs due to their systemic side effects, which include fatigue, depression, loss of appetite, weight loss, loss of libido, kidney stones, metallic taste and tingling in fingers and toes (peripheral neuropathies).

Parasympathomimetics. These drugs work by increasing the outflow of aqueous humor from the eye. They are frequently used to control IOP in narrow-angle glaucoma. These eye drops cause the pupil to constrict, which assists in opening the narrowed or blocked angle where drainage occurs. Common side effects experienced with these types of eye drops include brow ache, pupil constriction, burning, and reduced night vision. FDA-approved drugs in this class include pilocarpine, carbachol, echothiophate and demecarium.

Epinephrine. The epinephrine class of drugs has a dual effect on the eye. These drugs work by decreasing the rate of aqueous humor production and increasing the outflow of aqueous humor from the eye. Common side effects experienced with this classification of eye drop include pigmented eye surface membrane (conjunctival) deposits, blocked tear ducts and heart palpitations with an increased heart rate. The FDA-approved drugs in this class include epinephrine and Allergan’s Propine (dipivalyl epinephrine).

Beta-blockers. Used in a variety of glaucoma eye drops, beta-blockers were at one time the drugs of first choice in treating glaucoma. These drugs work by decreasing fluid (aqueous) production in the eye and now are often prescribed as an adjunct to or in combination with prostaglandins.

For convenience, two different types of glaucoma eye drops may be combined in one bottle.

Combination glaucoma drugs. Study results show that half of individuals with glaucoma require more than one type of medication to control IOP.* For this reason, a few ophthalmic pharmaceutical companies have produced “combination” eye drops that can include two different anti-glaucoma medicines in the same bottle.

For convenience, your eye doctor might prescribe combined IOP-lowering medications. Typically, these combined medications have the additive effect of reducing IOP. Examples of FDA-approved medications of this type include Cosopt (Merck), Combigan (Allergan) and DuoTrav (Alcon).

Investigational Glaucoma Treatments

While some experimental glaucoma medications explore new ways of controlling IOP, other treatments are directed at protecting the optic nerve (neuroprotection) to prevent eye damage, potential vision loss or even blindness.

Many ongoing clinical studies are trying to find neuroprotective agents that might benefit the optic nerve and certain retinal cells in glaucoma. Many of these agents were developed from the results of work done on other central nervous system diseases such as Parkinson’s and multiple sclerosis.

Using Marijuana for Glaucoma

Medical marijuana to treat glaucoma: does it work, or is it just wishful thinking?

Some people with glaucoma use marijuana because research conducted in the 1970s found that it had a small, short-term effect in lowering intraocular pressure.

However, no research has found that marijuana is anywhere near as effective as legal glaucoma medications.

In November 2010, researchers announced study results showing how marijuana suppresses the body‘s immune system and potentially makes users more susceptible to infection and growth of cancer cells. Findings were published in the European Journal of Immunology.

The American Academy of Ophthalmology, among other authoritative sources, says the risky side effects of marijuana (such as lowered blood pressure, increased heart rate, poor pregnancy outcomes, poor motor coordination, impaired memory and increased risk of cancer and emphysema) far outweigh any benefit.

Popular opinion persistently exaggerates the benefit of marijuana for glaucoma.

This is unfortunate, because people who use marijuana instead of their prescribed glaucoma medication run a big risk of having irreversible vision loss. — L.S.

Some investigational treatments are undergoing FDA clinical trials to prove safety and effectiveness. Other potential glaucoma treatments are strictly in experimental stages and may be years away from the possibility of being available on the marketplace.

Examples of neuroprotective agents under investigation for treatment of glaucoma include:

  • Namenda (memantine). As of late 2010, Allergan had made no announcements regarding future plans for developing Namenda as a possible treatment for protecting the optic nerve from glaucoma damage. The drug underwent late-stage FDA clinical trials as a potential glaucoma treatment, but reportedly did not show significant benefit for patients. Namenda originally was FDA-approved in 2003 for its neuroprotective effects in the treatment of Alzheimer‘s.
  • Copaxone (glatiramer acetate). Copaxone is an injectable drug currently used to treat patients with multiple sclerosis. Developed by Teva Pharmaceuticals, the drug also is being investigated as a possible neuroprotective agent to prevent damage to the optic nerve from the effects of glaucoma. Copaxone appears to protect the optic nerve from the direct toxic effects on nerve cells caused by increased IOP.
  • Gingko biloba. Some study results indicate that the herb gingko biloba might offer some protective effect for the optic nerve, which can be damaged by glaucoma. A small study reported in the February 2003 issue of Ophthalmology demonstrated that some individuals improved their ability to see a wider visual field following treatment with gingko biloba.

Other investigational treatments for glaucoma, aimed at controlling high IOP, include:

  • Latanoprost Punctal Plug Delivery System. During earlier FDA clinical trials, this drug delivery system by QLT Inc. involved inserting a tiny punctal plug into a drainage channel in the eye. During a 12-week period, the drug slowly was released to control high intraocular pressure associated with glaucoma. Early investigations originally showed the system might have potential as a drug delivery device. But at this time, the company is working on a different design to help improve results. This drug delivery method possibly could address problems with compliance among people who must use eye drops daily.
  • Nanoparticles. University of Central Florida researchers have reported promising results from experiments using laboratory-created nanoparticles to deliver a compound able to block enzymes that create carbon dioxide, which contributes to the buildup of internal eye pressure associated with glaucoma. Investigations into this approach to treating glaucoma are in very early stages.

    Buy Xalatan online

    Buy FDA approved medications.No Prior Prescription Needed – No delays.FedEx Overnight! – Discreet Unmarked Packages – Very Easy! Only Credit Cards – **ONLY U.S.A.**

    Cyclosporine Eye Drops Online Pharmacy

    Only FDA approved medications. FREE medical consultation. No prescription required. Confidentiality is assured.